Tags Reports - Allied Market Research

sale

Granisetron Market

U

2025

Granisetron Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and radiotherapy. Its major effect is to reduce the activity ...

Report Code : A12478 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Folliculotropic Mycosis Fungoides Treatment Market

U

2025

Folliculotropic Mycosis Fungoides Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Folliculotropic mycosis fungoides is a type of cutaneous T-cell lymphoma. This is a rare disease in which white blood cells (WBC) turn into cancerous cell due genetic mutation. ...

Report Code : A13192 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

3D Printed Drugs Market

P

2017

3D Printed Drugs Market:

3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary ...

Report Code : A04158 | Pages : 125 | Category : Life Sciences

Price:

~~$3,217~~ $1,705 (47% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Myelofibrosis Treatment Market

P

2022

Myelofibrosis Treatment Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global myelofibrosis treatment market was valued at $786.1 million in 2021, and is projected to reach $1,160.29 million by 2031, growing at a CAGR of 4% from 2022 to 2031.

Report Code : A15378 | Pages : 181 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

HER2-Positive Breast Cancer Market

U

2025

HER2-Positive Breast Cancer Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Human epidermal growth factor receptor 2 (HER2) is a gene that is linked to breast cancer development. Genes contain the recipes for numerous proteins required by a cell to remain healthy and function normally.

Report Code : A15411 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Global Ovarian Cancer Drugs Market

P

2022

Global Ovarian Cancer Drugs Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global ovarian cancer drugs market was valued at $2.3 billion in 2021, and is projected to reach $5.1 billion by 2031, growing at a CAGR of 8.4% from 2022 to 2031.

Report Code : A00273 | Pages : 189 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Skin Cancer Treatment Market

P

2022

Skin Cancer Treatment Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global skin cancer treatment market was valued at $7.2 billion in 2021, and is projected to reach $14.5 billion by 2031, growing at a CAGR of 7.3% from 2022 to 2031.

Report Code : A17526 | Pages : 251 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Sarcoma Drugs Market

P

2022

Sarcoma Drugs Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global sarcoma drugs market was valued at $1,127.0 million in 2021, and is projected to reach $2,497.1 million by 2031, growing at a CAGR of 8.3% from 2022 to 2031.

Report Code : A31578 | Pages : 220 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Antiemetics Market

P

2022

Antiemetics Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global antiemetics market was valued at $2.3 billion in 2021, and is projected to reach $4.1 billion by 2031, growing at a CAGR of 6.1% from 2022 to 2031.

Report Code : A00336 | Pages : 260 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Global Non Small-Cell Lung Cancer Market

P

2022

Global Non Small-Cell Lung Cancer Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global non small cell lung cancer market was valued at $15.3 billion in 2021, and is projected to reach $36.9 billion by 2031, growing at a CAGR of 9.3% from 2022 to 2031.

Report Code : A00544 | Pages : 262 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Multiple Myeloma Market

P

2023

Multiple Myeloma Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global multiple myeloma market was valued at $19,666.74 million in 2021, and is projected to reach $53,521.76 million by 2031, registering a CAGR of 10.5% from 2021 to 2031.

Report Code : A03384 | Pages : 411 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Leukemia Therapeutics Market

P

2023

Leukemia Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global leukemia therapeutics market size was valued at $7,818.63 million in 2021 and is estimated to reach $14,162.48 million by 2031, exhibiting a CAGR of 6.1% from 2022 to 2031.

Report Code : A01128 | Pages : 392 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Lymphoma Therapeutics Market

P

2023

Lymphoma Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The lymphoma therapeutics market was valued at $15,691.45 million in 2022 and is projected to reach $35,207.45 million by 2032, registering a CAGR of 8.4% from 2023 to 2032.

Report Code : A01129 | Pages : 481 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Neuroblastoma Drugs Market

P

2024

Neuroblastoma Drugs Market: Global Opportunity Analysis and Industry Forecast, 2022 - 2032

The global neuroblastoma drugs market was valued at $0.7 billion in 2022, and is projected to reach $1.3 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032.

Report Code : A172697 | Pages : 256 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Vinca Alkaloid Compounds Market

P

2024

Vinca Alkaloid Compounds Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global vinca alkaloid compounds market was valued at $81.0 million in 2023, and is projected to reach $161.5 million by 2033, growing at a CAGR of 7.2% from 2024 to 2033.

Report Code : A324538 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Closed System Drug Transfer Device

P

2024

Closed System Drug Transfer Device : Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global closed system drug transfer device (CSTD) market was valued at $0.8 billion in 2023, and is projected to reach $3.6 billion by 2033, growing at a CAGR of 15.7% from 2024 to 2033.

Report Code : A324072 | Pages : 216 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Cytotoxic Drug Market by Drug Type

P

2024

Cytotoxic Drug Market by Drug Type : Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global cytotoxic drug market was valued at $15.8 billion in 2023, and is projected to reach $19.5 billion by 2033, growing at a CAGR of 2.1% from 2024 to 2033.

Report Code : A324399 | Pages : 245 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Chemotherapy Induced Peripheral Neuropathy Treatment Market by Drug...

P

2024

Chemotherapy Induced Peripheral Neuropathy Treatment Market by Drug Class : Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global chemotherapy induced peripheral neuropathy treatment market was valued at $0.9 billion in 2023, and is projected to reach $1.6 billion by 2033, growing at a CAGR of 6.1% from 2024 to 2033.

Report Code : A324389 | Pages : 280 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Results for Tags: chemotherapy

Filter by Region

Filter by Discounts

Filter by Category

Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and radiotherapy. Its major effect is to reduce the activity ...

Folliculotropic mycosis fungoides is a type of cutaneous T-cell lymphoma. This is a rare disease in which white blood cells (WBC) turn into cancerous cell due genetic mutation. ...

3D Printed Drugs Market are medications, which are designed by 3D printing technique to customize for the individuals in a safer and effective way. These drugs have unitary ...

The global myelofibrosis treatment market was valued at $786.1 million in 2021, and is projected to reach $1,160.29 million by 2031, growing at a CAGR of 4% from 2022 to 2031.

Human epidermal growth factor receptor 2 (HER2) is a gene that is linked to breast cancer development. Genes contain the recipes for numerous proteins required by a cell to remain healthy and function normally.

The global ovarian cancer drugs market was valued at $2.3 billion in 2021, and is projected to reach $5.1 billion by 2031, growing at a CAGR of 8.4% from 2022 to 2031.

The global skin cancer treatment market was valued at $7.2 billion in 2021, and is projected to reach $14.5 billion by 2031, growing at a CAGR of 7.3% from 2022 to 2031.

The global sarcoma drugs market was valued at $1,127.0 million in 2021, and is projected to reach $2,497.1 million by 2031, growing at a CAGR of 8.3% from 2022 to 2031.

The global antiemetics market was valued at $2.3 billion in 2021, and is projected to reach $4.1 billion by 2031, growing at a CAGR of 6.1% from 2022 to 2031.

The global non small cell lung cancer market was valued at $15.3 billion in 2021, and is projected to reach $36.9 billion by 2031, growing at a CAGR of 9.3% from 2022 to 2031.

The global multiple myeloma market was valued at $19,666.74 million in 2021, and is projected to reach $53,521.76 million by 2031, registering a CAGR of 10.5% from 2021 to 2031.

The global leukemia therapeutics market size was valued at $7,818.63 million in 2021 and is estimated to reach $14,162.48 million by 2031, exhibiting a CAGR of 6.1% from 2022 to 2031.

The lymphoma therapeutics market was valued at $15,691.45 million in 2022 and is projected to reach $35,207.45 million by 2032, registering a CAGR of 8.4% from 2023 to 2032.

The global neuroblastoma drugs market was valued at $0.7 billion in 2022, and is projected to reach $1.3 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032.

The global vinca alkaloid compounds market was valued at $81.0 million in 2023, and is projected to reach $161.5 million by 2033, growing at a CAGR of 7.2% from 2024 to 2033.

The global closed system drug transfer device (CSTD) market was valued at $0.8 billion in 2023, and is projected to reach $3.6 billion by 2033, growing at a CAGR of 15.7% from 2024 to 2033.

The global cytotoxic drug market was valued at $15.8 billion in 2023, and is projected to reach $19.5 billion by 2033, growing at a CAGR of 2.1% from 2024 to 2033.

The global chemotherapy induced peripheral neuropathy treatment market was valued at $0.9 billion in 2023, and is projected to reach $1.6 billion by 2033, growing at a CAGR of 6.1% from 2024 to 2033.